Drugplain

TYZAVAN 2 g/400mL

Vancomycin · INJECTION, SOLUTION · Hikma Pharmaceuticals USA Inc.

No Recall HistoryCurrently in Shortage
Plain English

TYZAVAN is a injection, solution containing vancomycin at 2 g/400mL, taken intravenous. Manufactured by Hikma Pharmaceuticals USA Inc..

Key Facts

Brand Name
TYZAVAN
Generic Name
Vancomycin
NDC Code (Product)
0143-9470
Manufacturer
Hikma Pharmaceuticals USA Inc.
Strength
2 g/400mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
NDA211962
Drug Class
Glycopeptide Antibacterial [EPC]
Marketing Start
10/17/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective6,285 reports
acute kidney injury4,254 reports
off label use4,085 reports
pyrexia3,550 reports
drug reaction with eosinophilia and systemic symptoms2,350 reports
renal failure2,209 reports
sepsis2,080 reports
diarrhoea2,065 reports
pneumonia1,921 reports
hypotension1,898 reports

Frequently Asked Questions

What is TYZAVAN used for?

TYZAVAN contains Vancomycin. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is TYZAVAN a controlled substance?

TYZAVAN is not classified as a controlled substance by the DEA.

What is the generic name for TYZAVAN?

The generic name for TYZAVAN is Vancomycin. There are 11 other brand versions of Vancomycin.

What is the NDC code for TYZAVAN 2 g/400mL?

The NDC (National Drug Code) for TYZAVAN 2 g/400mL is 0143-9470, listed by Hikma Pharmaceuticals USA Inc..